The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the ...

A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending ...

A new pioneering Alzheimer's drug has been rejected for widespread use in the NHS in England. The announcement comes as the ...

The U.K. watchdog declines to endorse Eli Lilly's Alzheimer's drug donanemab, citing lack of value for the NHS and ...

A drug that can slow the progression of Alzheimer's disease has been blocked for use on the NHS due to cost concerns.

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

Donanemab has been hailed as 'game changer' but the price tag has barred it from being available to nearly one million Brits.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved US pharma major Eli Lilly’s Kisunla (donanemab ...

The UK’s healthcare spending watchdog has rejected Eli Lilly’s (LLY) Alzheimer’s drug as being too expensive despite being ...